VS
stockvs
Go to ScreenerHub
0QQ6.L

0QQ6.L vs MRK

MRK

In the past 12 months, MRK returned +55% while 0QQ6.L gained 20%.

0QQ6.L
0QQ6.L

Roche Holding AG

$431.14
4.0%(1M)
Market Cap368.3B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio20.35
ROE41.2%
P/B Ratio7.75
Dividend Yield3.0%
MRK
MRK

Merck & Co., Inc.

$118.72
7.0%(1M)
Market Cap293.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio32.85
ROE17.9%
P/B Ratio6.40
Dividend Yield2.8%
Performance Comparison

Historical returns across multiple timeframes

MRK leads 8/8
0QQ6.L

0QQ6.L

Roche Holding AG

+19.8%

1Y Return

MRK

MRK

Merck & Co., Inc.

+55.4%

1Y Return

0QQ6.L
0QQ6.L
MRK
MRK

Short Term

1M-6M

MRK
+5.4%

Medium Term

YTD-1Y

MRK
+34.1%

Long Term

3Y-10Y

MRK
+65.2%

Valuation

Compare price multiples and valuation ratios

0QQ6.L: 3MRK: 2
Metric0QQ6.LMRKWinner
P/E Ratio

Price to earnings ratio

20.3532.850QQ6.L
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

4.264.470QQ6.L
P/B Ratio

Price to book ratio

7.756.40MRK
P/FCF Ratio

Price to free cash flow ratio

22.0820.77MRK
EV/EBITDA

Enterprise value to EBITDA

12.7214.850QQ6.L
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

0QQ6.L: 5MRK: 1
Metric0QQ6.LMRKWinner
Gross Margin

Gross profit margin

73.5%75.9%MRK
Operating Margin

Operating profit margin

28.9%27.6%0QQ6.L
Net Margin

Net profit margin

20.9%13.6%0QQ6.L
ROE

Return on equity

41.2%17.9%0QQ6.L
ROA

Return on assets

12.8%6.9%0QQ6.L
ROIC

Return on invested capital

18.8%13.3%0QQ6.L

Growth

Compare revenue and earnings growth rates

0QQ6.L: 1MRK: 5
Metric0QQ6.LMRKWinner
Revenue Growth (YoY)

Year-over-year revenue growth

-1.4%1.2%MRK
Revenue Growth (3Y)

3-year revenue CAGR

-0.9%3.1%MRK
Revenue Growth (5Y)

5-year revenue CAGR

1.1%9.4%MRK
EPS Growth (YoY)

Year-over-year EPS growth

55.9%8.0%0QQ6.L
EPS Growth (3Y)

3-year EPS CAGR

1.1%8.4%MRK
EPS Growth (5Y)

5-year EPS CAGR

-0.6%21.2%MRK

Balance Sheet & Risk

Compare financial stability and debt levels

0QQ6.L: 3MRK: 2
Metric0QQ6.LMRKWinner
Debt/Equity

Debt to equity ratio

0.941.070QQ6.L
Current Ratio

Current assets to current liabilities

1.381.300QQ6.L
Quick Ratio

Quick assets to current liabilities

1.121.060QQ6.L
Interest Coverage

EBIT to interest expense

13.1617.35MRK
Beta

Stock volatility vs market

0.330.20MRK
Summary
0QQ6.L wins 3-1

Valuation

0QQ6.L

Profitability

0QQ6.L

Growth

MRK

Balance Sheet

0QQ6.L

0QQ6.L is more attractively valued. 0QQ6.L shows stronger profitability. MRK demonstrates better growth. 0QQ6.L has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into 0QQ6.L and MRK with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/0QQ6.L/vs/MRK" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare 0QQ6.L vs MRK on stockvs.app
</a>